| Ticker Details |
|
Ginkgo Bioworks Holdings, Inc.
|
| IPO Date: |
September 17, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$592.49M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.28 | 4.90%
|
| Avg Daily Range (30 D): |
$0.28 | 3.12%
|
| Avg Daily Range (90 D): |
$0.32 | 4.07%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.86M |
| Avg Daily Volume (30 D): |
1.12M |
| Avg Daily Volume (90 D): |
1.13M |
| Trade Size |
| Avg Trade Size (Sh.): |
28 |
| Avg Trade Size (Sh.) (30 D): |
77 |
| Avg Trade Size (Sh.) (90 D): |
80 |
| Institutional Trades |
| Total Institutional Trades: |
2,356 |
| Avg Institutional Trade: |
$1.75M |
| Avg Institutional Trade (30 D): |
$1.33M |
| Avg Institutional Trade (90 D): |
$1.07M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.51M |
| Avg Closing Trade (30 D): |
$1.42M |
| Avg Closing Trade (90 D): |
$1.12M |
| Avg Closing Volume: |
64.56K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-5.36
|
$-1.39
|
$-1.42
|
|
Diluted EPS
|
|
|
$-1.42
|
|
Revenue
|
$141.31M
|
$19.47M
|
$33.4M
|
|
Gross Profit
|
|
$16.38M
|
|
|
Net Income / Loss
|
$-304.39M
|
$-82.59M
|
$-80.75M
|
|
Operating Income / Loss
|
$-297.68M
|
$-71.37M
|
$-70.75M
|
|
Cost of Revenue
|
|
$3.1M
|
|
|
Net Cash Flow
|
$-166.74M
|
$-23.7M
|
$55.41M
|
|
PE Ratio
|
|
|
|
|
|
|